EFFECT OF FAMILY HISTORY AND GENETIC POLYMORPHISMS ON RISK AND AGGRESSIVENESS PATTERNS OF PROSTATE CANCER

被引：0
|
作者：
Drouin, S. J. [1 ]
Cornu, J. N. [1 ]
Roupret, M. [1 ]
Cancel-Tassin, G. [2 ]
Cormier, L. [2 ]
Azzouzi, A. R. [2 ]
Mangin, P. [2 ]
Haab, F. [1 ]
Bitker, M. O. [1 ]
Cussenot, O. [1 ]
机构：
[1] Univ Paris 06, APHP, GHU Est, Dept Urol, Paris, France
[2] CeRePP, Dept Urol, Paris, France
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2011年 / 10卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(11)60509-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [41] The family history component of cancer genetic risk counseling
    Loescher, LJ
    CANCER NURSING, 1999, 22 (01) : 96 - 102
  • [42] GENETIC RISK VARIANTS ON 8Q24 ASSOCIATED WITH PROSTATE CANCER AGGRESSIVENESS
    Helfand, Brian T.
    Hofer, Matthias D.
    Hu, Qiaoyan
    McGuire, Barry B.
    O'Brien, Daniel C.
    Catalona, William J.
    JOURNAL OF UROLOGY, 2011, 185 (04): : E287 - E288
  • [43] Comparison of Two Methods for Estimating Absolute Risk of Prostate Cancer Based on Single Nucleotide Polymorphisms and Family History
    Hsu, Fang-Chi
    Sun, Jielin
    Zhu, Yi
    Kim, Seong-Tae
    Jin, Tao
    Zhang, Zheng
    Wiklund, Fredrik
    Kader, A. Karim
    Zheng, S. Lilly
    Isaacs, William
    Gronberg, Henrik
    Xu, Jianfeng
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (04) : 1083 - 1088
  • [44] Family History and Genetic Testing for Cancer Risk REPLY
    Steiner, Elizabeth
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (08) : 938 - 938
  • [45] The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer
    Roco, Angela
    Lavanderos, Alejandra
    Cayun, Juan P.
    Acevedo, Cristian
    Celedon, Cesar
    Rubilar, Juan C.
    Sandoval, Christopher
    Cerpa, Leslie
    Garcia-Martin, Elena
    Agundez, Jose A.
    Esguevillas, Gara
    Amo, Gemma
    Canepa, Angelo
    Cerda, Berta
    Pena, Karina
    Caceres, Dante D.
    Varela, Nelson M.
    Quinones, Luis A.
    PHARMACOGENETICS AND GENOMICS, 2019, 29 (07): : 159 - 166
  • [46] Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer
    Liu, Yunguang
    Lin, Na
    Huang, Li
    Xu, Qunqing
    Pang, Guangfu
    DNA AND CELL BIOLOGY, 2007, 26 (08) : 613 - 618
  • [47] Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia
    Negri, E
    Pelucchi, C
    Talamini, R
    Montella, M
    Gallus, S
    Bosetti, C
    Franceschi, S
    La Vecchia, C
    INTERNATIONAL JOURNAL OF CANCER, 2005, 114 (04) : 648 - 652
  • [48] DNA-repair genetic polymorphisms and prostate cancer risk.
    Clark, PE
    Hall, MC
    Lockett, KL
    Xu, JF
    Zheng, SL
    Chuang, SC
    Hu, J
    JOURNAL OF UROLOGY, 2005, 173 (04): : 71 - 71
  • [49] COST-EFFECTIVENESS OF CHEMOPREVENTION WITH FINASTERIDE FOR PROSTATE CANCER VARIES ACROSS SUBGROUPS DEFINED BY FAMILY HISTORY AND GENETIC POLYMORPHISMS
    Reed, Shelby
    Scales, Charles
    Stewart, Suzanne
    Sun, Jielin
    Moul, Judd
    Schulman, Kevin
    Xu, Jianfeng
    JOURNAL OF UROLOGY, 2010, 183 (04): : E132 - E133
  • [50] History of PSA screening on prostate cancer aggressiveness.
    Cullen, Jennifer
    Gerald, Thomas
    Burke, Allen
    Kuo, Huai-Ching
    Rosner, Inger L.
    Srivastava, Shiv
    Sesterhenn, Isabell
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345